149 results on '"Naugler, Willscott E."'
Search Results
2. AAV integration in human hepatocytes
3. In vitro expansion of cirrhosis derived liver epithelial cells with defined small molecules
4. Multidisciplinary Team Management of Hepatocellular Carcinoma Is Standard of Care
5. The fate of anti-HLA antibodies following liver transplantation.
6. The Genetics of HIV-1
7. Safety and Efficacy of Accelerated Hypofractionation and Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma Patients With Varying Degrees of Hepatic Impairment
8. Thromboelastography Better Reflects Hemostatic Abnormalities in Cirrhotics Compared With the International Normalized Ratio
9. Correction to: Yttrium-90 Radioembolization for BCLC Stage C Hepatocellular Carcinoma Comparing Child–Pugh A Versus B7 Patients: Are the Outcomes Equivalent?
10. Malignant Infiltration of the Liver Presenting as Acute Liver Failure
11. Building the Multidisciplinary Team for Management of Patients With Hepatocellular Carcinoma
12. Hepatitis C and Hepatocellular Carcinoma
13. Marked Decrease in Urgent Listing for Liver Transplantation Over Time: Evolution of Characteristics and Outcomes of Status-1 Liver Transplantation
14. Symptom Distress in Patients With Hepatocellular Carcinoma Toward the End of Life
15. Carcinoid Tumors
16. Bridge-to-transplant stereotactic body radiation therapy in patients with hepatocellular carcinoma and advanced cirrhosis.
17. Gender Disparity in Liver Cancer Due to Sex Differences in MyD88-Dependent IL-6 Production
18. Epstein–Barr Virus (EBV) Related Acute Liver Failure: A Case Series from the US Acute Liver Failure Study Group
19. T69D/N pol Mutation, Human Immunodeficiency Virus Type 1 RNA Levels, and Syncytium-Inducing Phenotype Are Associated with CD4 Cell Depletion during Didanosine Therapy
20. Liver progenitor cells are derived from mature hepato-cytes: 146
21. The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancer
22. Waiting time predicts survival after liver transplantation for hepatocellular carcinoma: A cohort study using the United Network for Organ Sharing registry
23. Liver Injury Increases the Incidence of HCC following AAV Gene Therapy in Mice
24. Portal Biliopathy Causing Recurrent Biliary Obstruction and Hemobilia
25. Combined locoregional and systemic therapy for advanced hepatocellular carcinoma: finally, the future is obscure
26. Impact of locoregional therapy and alpha-fetoprotein on outcomes in transplantation for liver cancer: a UNOS Region 6 pooled analysis
27. Hepatocellular Proliferation and Metabolic Syndrome Risk Factors are Increased in Non-Cirrhotic Hepatocellular Carcinoma: A Case-Control Study: 557
28. Sex Does Matter in Liver Allocation—Time to Address Existing Sex-Based Disparities
29. Survival and cost-effectiveness analysis of competing strategies in the management of small hepatocellular carcinoma
30. Thromboelastography Better Reflects Hemostatic Abnormalities in Cirrhotics Compared With the International Normalized Ratio
31. Models of influence in chronic liver disease
32. 2 The Genetics of HIV-1
33. Battle Royale: Systemic Versus Locoregional Therapy for Unresectable Hepatocellular Carcinoma
34. Ganja, No Barrier for Liver Transplantation?
35. Long-Term Correction of Diabetes in Mice by In Vivo Reprogramming of Pancreatic Ducts
36. Ectopic expansion of engineered human liver tissue seeds using mature cell populations
37. A propensity matched survival analysis comparing treatment strategies for stage B and C hepatocellular carcinoma
38. Safety and efficacy of accelerated hypofractionation and stereotactic body radiotherapy for hepatocellular carcinoma in the setting of advanced liver dysfunction.
39. Higher Mortality and Survival Benefit in Obese Patients Awaiting Liver Transplantation
40. Fibroblast Growth Factor Signaling Controls Liver Size in Mice With Humanized Livers
41. Bipotential Adult Liver Progenitors Are Derived from Chronically Injured Mature Hepatocytes
42. NF-κB and cancer
43. Carcinoid Tumors
44. Bile Acid Flux Is Necessary for Normal Liver Regeneration
45. Who should undergo liver transplantation for hepatocellular carcinoma? Ablate, wait … and see!
46. Long-Term Correction of Diabetes in Mice by In VivoReprogramming of Pancreatic Ducts
47. Impact of locoregional therapy and alpha-fetoprotein on outcomes in transplantation for liver cancer: a UNOS Region 6 pooled analysis
48. Hepatocellular Carcinoma
49. NF-κB and cancer—identifying targets and mechanisms
50. Comparison of Oligonucleotide Ligation Assay and Consensus Sequencing for Detection of Drug-Resistant Mutants of Human Immunodeficiency Virus Type 1 in Peripheral Blood Mononuclear Cells and Plasma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.